Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia
Go back to Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia| Uni-Pixel, Inc. (NASDAQ: NXL) | Delayed: 4.90 -0.2 (3.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.10 | 52 Week High | $0.68 | |||
| Open | $5.06 | 52 Week Low | $0.62 | |||
| Day High | $5.36 | P/E | N/A | |||
| Day Low | $4.73 | EPS | $0.00 | |||
| Volume | 14,995 | |||||
